ArticleHepatology (Baltimore, Md.)2019

Inhibition of Cyclin-Dependent Kinase 5: A Strategy to Improve Sorafenib Response in Hepatocellular Carcinoma Therapy.

Maximilian A Ardelt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.